Orthocell reports strong interim results from Remplir real-world evidence study

Regenerative medicine company Orthocell (ASX:OCC) has reported promising interim results from its ongoing Remplir Real-World Evidence study, reinforcing the performance of its collagen nerve wrap in routine clinical practice and laying the groundwork for international expansion. …